Vitamin D Deficiency and Hair Loss: Clinical Evidence and Mechanisms

Vitamin D Deficiency and Hair Loss: Clinical Evidence and Mechanisms

"A systematic review and meta-analysis of 14 observational studies found that mean serum 25-hydroxyvitamin D was significantly lower in people with alopecia areata than in controls, although no clear correlation emerged between vitamin D level and the extent of hair loss."

Lee S, Kim BJ, Lee CH, Lee WS. J Eur Acad Dermatol Venereol. 2018;32(7):1214-1221

Pattern hair loss is common: male androgenetic alopecia affects an estimated 30-50% of men by age 50, and it is also prevalent in women [1]. Patients increasingly ask whether vitamin D deficiency plays a role. The question has biological merit: vitamin D receptors are expressed in hair follicles, and several observational studies report lower serum 25-hydroxyvitamin D [25(OH)D] levels in people with specific hair-loss conditions [2]. Those findings raise the possibility that vitamin D status influences the hair growth cycle, though the strength of the evidence varies by condition and none of it establishes cause and effect.

This brief examines the research linking vitamin D status to hair follicle biology, reviews clinical data on deficiency and hair-loss disorders, and outlines what is known—and what remains uncertain—about supplementation. Our goal is to give you the evidence you need to interpret your own vitamin D levels in the context of hair health.

What is Vitamin D?

Vitamin D is a fat-soluble nutrient and hormone precursor synthesized in skin when ultraviolet B radiation converts 7-dehydrocholesterol to cholecalciferol (vitamin D3). It can also be obtained from a small number of foods and from supplements. Once in circulation, vitamin D undergoes two hydroxylation steps—first in the liver to 25-hydroxyvitamin D [25(OH)D], the form used to assess status, then mainly in the kidneys to 1,25-dihydroxyvitamin D [1,25(OH)2D], the active hormone [3].

The active form binds the vitamin D receptor (VDR), a nuclear receptor expressed in many tissues, including bone, immune cells, and epithelial structures such as keratinocytes. VDR signaling influences the expression of a wide range of genes involved in calcium homeostasis, cell proliferation, differentiation, and immune function [3]. Serum 25(OH)D is the clinical marker of status. The Endocrine Society classifies levels below 20 ng/mL as deficient, 21-29 ng/mL as insufficient, and 30 ng/mL or above as sufficient [4], while the Food and Nutrition Board considers levels of 20 ng/mL (50 nmol/L) and above adequate for bone and overall health in most people [3]. Laboratory reference ranges differ accordingly.

Low status is common. In NHANES 2011-2014 data, 18% of people in the United States aged 1 year and older were at risk of inadequacy (30-49 nmol/L, or 12-19.6 ng/mL) and 5% were at risk of deficiency (below 30 nmol/L, or 12 ng/mL); the proportion at risk of deficiency peaked at 7.6% in adults aged 20-39 years [3]. Risk is higher in winter, at northern latitudes, among people with darker skin, and in populations with predominantly indoor lifestyles. That has driven interest in vitamin D's role beyond bone health, including its potential influence on hair growth.

What is Vitamin D's Role in Hair Biology?

Hair follicles cycle through three phases: anagen (active growth, lasting years), catagen (regression, lasting a few weeks), and telogen (rest, lasting a few months). Transitions between phases are tightly regulated, and disruption can lead to excessive shedding or follicle miniaturization. Vitamin D receptor expression has been documented in keratinocytes and in the outer root sheath of hair follicles, which is the basis for proposing a role in follicle cycling and differentiation [2][5].

Animal work provides the clearest mechanistic data. Mice lacking the VDR are born with a normal coat but fail to initiate normal hair follicle cycling and develop alopecia, and the alopecia persists even when mineral ion homeostasis is normalized by diet—indicating that it is not simply a consequence of abnormal calcium metabolism [6]. Alopecia was not seen in animals that lacked vitamin D itself rather than the receptor, and hair-reconstitution experiments localized the defect to keratinocytes, pointing to impaired epithelial-mesenchymal communication required for normal cycling [6]. In humans, VDR gene variants have been examined in relation to androgenetic alopecia with inconsistent results, and no causal relationship has been established [2].

Importantly, keratinocytes possess the enzymatic machinery to convert vitamin D locally to 1,25(OH)2D and express the VDR, so skin and follicles can regulate vitamin D signaling to a degree independently of circulating hormone levels [5]. That local metabolism complicates the interpretation of serum 25(OH)D as a proxy for follicular vitamin D activity. Systemic deficiency may nonetheless limit substrate for local conversion, which is one rationale for measuring serum levels in patients with hair loss.

Clinical Evidence Linking Vitamin D Deficiency to Hair Loss

Observational studies have reported associations between low serum 25(OH)D and several hair-loss conditions, though the evidence is stronger for some disorders than others. The most consistent findings involve alopecia areata and female-pattern hair loss; data in men with androgenetic alopecia are weaker [7].

Telogen Effluvium

Telogen effluvium (TE) is characterized by diffuse shedding as follicles shift prematurely from anagen to telogen, often triggered by physiological stress, illness, nutritional deficiency, or hormonal change. In an Egyptian case-control study of 80 women aged 18-45 with TE or female-pattern hair loss and 40 age-matched women without hair loss, serum vitamin D averaged 28.8 +/- 10.5 nmol/L (about 11.5 ng/mL) in the TE group and 29.1 +/- 8.5 nmol/L in the female-pattern group, versus 118.2 +/- 68.1 nmol/L (about 47 ng/mL) in controls (p < 0.001), with levels falling as disease severity increased [8]. Whether low vitamin D is a cause, a consequence, or a marker of shared risk factors cannot be determined from this design.

In an Egyptian case-control study, serum vitamin D averaged 28.8 nmol/L in women with telogen effluvium compared with 118.2 nmol/L in women without hair loss, and levels decreased as severity increased.

A 2024 systematic review and meta-analysis found that 53.51% of patients with TE had vitamin D deficiency, with a pooled unstandardized mean difference versus controls of -5.71 ng/mL (95% CI -10.10 to -1.32) [7]. These are correlational data, but they are consistent with the hypothesis that low vitamin D status is common among people with diffuse shedding.

Alopecia Areata

Alopecia areata (AA) is an autoimmune condition in which immune cells target hair follicles, causing patchy hair loss. Because vitamin D modulates immune function, researchers have asked whether low status relates to disease activity. A 2018 systematic review and meta-analysis of 14 observational studies (1,255 AA patients, 784 controls) found mean serum 25(OH)D 8.52 ng/mL lower in AA patients (95% CI -11.53 to -5.50), with roughly four-fold higher odds of vitamin D deficiency (odds ratio 3.89; 95% CI 2.02 to 7.49) and a mean deficiency prevalence of 73.8% among AA patients [9].

Contrary to a common claim, that meta-analysis did not find a clear relationship between serum 25(OH)D and the extent of hair loss; the authors reported that such a correlation was difficult to establish across studies [9]. All included studies were observational, so reverse causation—reduced sun exposure or dietary change following hair loss—cannot be excluded. A review of micronutrients in AA likewise found no significant association between dietary, supplemental, or total vitamin D intake and the risk of developing AA in prospective data [10].

Androgenetic Alopecia

Androgenetic alopecia (AGA)—male- and female-pattern hair loss—is driven primarily by androgen sensitivity in genetically predisposed follicles [1]. Evidence on vitamin D is uneven. In a case-control study of 45 women with female-pattern hair loss and 45 age-, sun-exposure- and BMI-matched controls, serum vitamin D3 was significantly lower in patients (P = 0.04) [11]. Pooled data agree for women: a mean difference of -15.67 ng/mL (95% CI -24.55 to -6.79) versus controls [7]. In men, the same analysis found a much smaller pooled difference of -2.19 ng/mL and an odds ratio for deficiency that was not statistically significant (4.42; 95% CI 0.53 to 36.61); the authors concluded the association with deficiency was clear only in alopecia areata and female-pattern hair loss [7].

No trial has shown that vitamin D supplementation slows androgenetic hair loss. For now, concerns about vitamin D and common hair thinning patterns rest on associations rather than demonstrated effects.

Study data chart

Intervention Studies: Does Supplementation Help?

Placebo-controlled trials of vitamin D supplementation for hair loss are essentially absent. The closest evidence comes from small uncontrolled or partially controlled studies. In a 2023 study of 40 Egyptian women with TE and 20 matched healthy controls, mean serum 25(OH)D was 13.31 +/- 5.8 ng/mL in patients versus 33.61 +/- 8.16 ng/mL in controls (P < 0.001); after three months of oral vitamin D, patient levels rose to 38.4 +/- 15.22 ng/mL (P < 0.001) [12]. Because no untreated patient group was followed in parallel, any clinical change over those three months cannot be attributed to vitamin D rather than to resolution of the underlying trigger.

No placebo-controlled trials have tested vitamin D supplementation in alopecia areata or androgenetic alopecia, and reviews of micronutrients in AA conclude that evidence is insufficient to recommend supplementation as a treatment, while noting it is reasonable to correct documented deficiency [10]. Uncontrolled case reports of regrowth are difficult to interpret because spontaneous remission occurs in up to 80% of patients with limited patchy AA within one year [13].

The absence of robust intervention data means it cannot be said that correcting vitamin D deficiency will reverse hair loss, even when deficiency is documented. What can be said is that low vitamin D status is frequently observed in certain hair-loss populations, and that correcting a deficiency is worthwhile on general health grounds [3].

Clinical Considerations

Who Should Consider Vitamin D Testing?

  • Patients with diffuse shedding or autoimmune hair loss: Given the observational links to telogen effluvium and alopecia areata [7][9], checking 25(OH)D is reasonable when other contributors (thyroid dysfunction, iron deficiency, recent illness or stress) are also being evaluated.
  • Individuals at higher risk of low vitamin D status: This includes people with darker skin, those living at northern latitudes or during winter months, and anyone with limited sun exposure or fat malabsorption, including celiac disease and inflammatory bowel disease [3].
  • Patients being evaluated for other reasons: Fatigue, bone or muscle pain, or unexplained weight changes may prompt testing independent of hair concerns.

Supplementation Guidelines

  • Deficiency (25(OH)D below 20 ng/mL): The Endocrine Society guideline describes 50,000 IU of vitamin D weekly for 8 weeks (or an equivalent daily dose) to raise levels above 30 ng/mL, followed by maintenance therapy [4].
  • Maintenance: At least 1,500-2,000 IU daily may be needed to keep 25(OH)D above 30 ng/mL in adults, with requirements varying by body weight, baseline level and sun exposure [4]. The Recommended Dietary Allowance is 600 IU daily for adults up to age 70 and 800 IU thereafter [3].
  • Vitamin K2: Osteocalcin and matrix Gla protein are vitamin K-dependent proteins; matrix Gla protein is studied for a possible role in limiting abnormal calcification, and adequate vitamin K intake (adequate intake 90 mcg daily for women and 120 mcg daily for men) supports their activation [14]. Routine co-supplementation with vitamin D has not been shown in trials to be necessary, and it has no demonstrated effect on hair.

Monitoring and Safety

  • Upper limits: The tolerable upper intake level for adults is 4,000 IU (100 mcg) daily. Toxicity is typically associated with serum 25(OH)D above 150 ng/mL (375 nmol/L) and with sustained intakes far above the upper limit; it should be managed with clinical supervision [3].
  • Retest timing: Serum 25(OH)D responds over weeks to months; rechecking roughly 3 months after a consistent dose is started is a practical way to confirm the target has been reached [4].
  • Adjunctive assessment: Hair loss is multifactorial. If vitamin D is low, it is reasonable to also evaluate ferritin and thyroid-stimulating hormone, which are commonly assessed in shedding disorders [10].

How to Choose a Vitamin D Supplement

  • Form: A meta-analysis of randomized trials comparing the two forms found vitamin D3 (cholecalciferol) more effective than D2 (ergocalciferol) at raising serum 25(OH)D, though the authors noted substantial heterogeneity between studies [15]. Choose D3 unless you need a plant-sourced D2 product.
  • Dosage: For maintenance in adults, roughly 1,000-2,000 IU daily is a common choice, within the 4,000 IU daily upper limit [3][4]. Higher correction regimens, such as 50,000 IU weekly for 8 weeks, belong under clinical guidance [4].
  • Co-formulation with vitamin K2: Combined D3 plus K2 (MK-7) products are widely sold; vitamin K is required for activation of osteocalcin and matrix Gla protein [14], but added benefit from routine co-supplementation has not been established in trials.
  • Third-party testing: Look for products verified by NSF International, USP, or ConsumerLab to confirm label accuracy and purity.
  • Delivery format: Vitamin D is fat-soluble, and absorption is generally better when it is taken with a meal containing fat [3]. Softgels often use an oil carrier such as MCT or olive oil.

Conclusion

The association between low serum 25(OH)D and hair loss is most consistent for alopecia areata and female-pattern hair loss, and is also reported in telogen effluvium [7][9]. Biological plausibility comes from vitamin D receptor expression in keratinocytes and hair follicles and from VDR-null mouse models, in which loss of receptor function disrupts hair cycling [5][6]. In men with androgenetic alopecia, pooled data show little difference from controls [7].

Intervention data remain thin: there are no placebo-controlled trials showing that supplementation improves hair loss, and the available studies are small and uncontrolled [10][12]. Given how often low vitamin D status occurs—particularly in winter, at northern latitudes, and among people with darker skin or indoor lifestyles [3]—measuring 25(OH)D in patients with unexplained hair loss is a low-cost step within a broader workup, and correcting a documented deficiency is sensible for general health [4]. It should not be presented as a treatment for hair loss. Anyone considering higher-dose supplementation should confirm the need with a blood test and stay within established upper limits [3].

Holistic Nutrition's Vitamin D3 + K2 pairs D3 with MK-7, calcium, and BioPerine — addressing the full absorption mechanism reviewed here.

Shop Now →

This article is part of the Holistic Nutrition Research Library. Browse all research briefs and ingredient factsheets.

References

[1] Asfour L, Cranwell W, Sinclair R. Male androgenetic alopecia. In: Feingold KR, Anawalt B, Blackman MR, et al, eds. Endotext. MDText.com Inc; updated January 25, 2023.

[2] Gerkowicz A, Chyl-Surdacka K, Krasowska D, Chodorowska G. The role of vitamin D in non-scarring alopecia. Int J Mol Sci. 2017;18(12):2653.

[3] National Institutes of Health Office of Dietary Supplements. Vitamin D: fact sheet for health professionals. Accessed 2025. https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/

[4] Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911-1930.

[5] Bikle DD. Vitamin D metabolism and function in the skin. Mol Cell Endocrinol. 2011;347(1-2):80-89.

[6] Sakai Y, Kishimoto J, Demay MB. Metabolic and cellular analysis of alopecia in vitamin D receptor knockout mice. J Clin Invest. 2001;107(8):961-966.

[7] Yongpisarn T, Tejapira K, Thadanipon K, Suchonwanit P. Vitamin D deficiency in non-scarring and scarring alopecias: a systematic review and meta-analysis. Front Nutr. 2024;11:1479337.

[8] Rasheed H, Mahgoub D, Hegazy R, et al. Serum ferritin and vitamin D in female hair loss: do they play a role? Skin Pharmacol Physiol. 2013;26(2):101-107.

[9] Lee S, Kim BJ, Lee CH, Lee WS. Increased prevalence of vitamin D deficiency in patients with alopecia areata: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2018;32(7):1214-1221.

[10] Thompson JM, Mirza MA, Park MK, Qureshi AA, Cho E. The role of micronutrients in alopecia areata: a review. Am J Clin Dermatol. 2017;18(5):663-679.

[11] Banihashemi M, Nahidi Y, Meibodi NT, Jarahi L, Dolatkhah M. Serum vitamin D3 level in patients with female pattern hair loss. Int J Trichology. 2016;8(3):116-120.

[12] El-Tatawy RA, Gheida S, Soliman GAM, Ismail M. Oral vitamin D treatment in patients with telogen effluvium: clinical and dermoscopic evaluation. Int J Trichology. 2023;15(5):183-190.

[13] Ito T. Advances in the management of alopecia areata. J Dermatol. 2012;39(1):11-17.

[14] National Institutes of Health Office of Dietary Supplements. Vitamin K: fact sheet for health professionals. Accessed 2025. https://ods.od.nih.gov/factsheets/VitaminK-HealthProfessional/

[15] Tripkovic L, Lambert H, Hart K, et al. Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. Am J Clin Nutr. 2012;95(6):1357-1364.


Leave a comment

This site is protected by hCaptcha and the hCaptcha Privacy Policy and Terms of Service apply.